← FDA Drug Approvals (Drugs@FDA)
BIMZELX
BLA · Biologics License Application · Sponsor: UCB INC · Approved 2023-10-17
Drug application
- FDA Application #
BLA761151- Application type
- Biologics License Application
- Brand name
- BIMZELX
- Generic name
- BIMEKIZUMAB
- Active ingredients
- BIMEKIZUMAB-BKZX
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- UCB INC
- Manufacturer
- UCB, Inc.
- First approval
- 2023-10-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown